These are some very bold claims with no explanation as to why you think this or how it will come to happen.
Do you think these approvals will happen without further studies? If so, why?
CHF will require further studies. Still waiting on the CLBP trial, that may have some surprising results I guess, fingers crossed.
Hopefully Novartis looks past the recent trial failures and decides to continue with the partnership, I'm surprised we haven't had any formal updates about that yet.
As far as the analysis of the covid trial goes, there may be some exciting results that weren't expected. But realistically they'll need to perform more studies to validate those findings.
I worry there doesn't seem to be a path for revenue in the short to medium term. Without a partnership, what are people's thoughts on the need for a cap raise?
MSB Price at posting:
$2.41 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)